Collaboration will aim to address challenge of timely and costly AAV-based vector manufacturing

At six and a half years 49% of patients treated with combination therapy remained alive

First targeted treatment authorised in the US for NSCLC patients with EGFR exon 20 insertion mutations

First one-time gene therapy for CALD among latest recommendations

Self-organizing heart organoids developed at IMBA – Institute of Molecular Biotechnology of the Austrian Academy of Sciences – […]

A team of Spanish researchers have developed, at the laboratory level, a prototype of a new biosensor to […]

Updated Date: Fri, 14 May 2021 00:00:00 EDT

Updated Date: Fri, 14 May 2021 00:00:00 EDT

Updated Date: Fri, 14 May 2021 00:00:00 EDT

Updated Date: Fri, 14 May 2021 00:00:00 EDT